• Riboxx Pharmaceuticals GmbH, of Radebeul, Germany, began a research collaboration with China National Biotech Group Co. Ltd., of Beijing, evaluating Riboxxim with one of CNBG's antigen's for an infectious disease.
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription
